2019 Communication Patient Care 
Viseven
JANUARY 9, 2023
Imagine this as a patient when you are under extreme duress and walk into a clinic or hospital; clear communication is often not feasible. Compelling and well-enunciated communications are quite rare between patient and doctor. Importance of Quality Patient-Doctor Communication.
pharmaphorum
FEBRUARY 5, 2021
The post-marketing ORAL Surveillance safety study showed that JAK inhibitor Xeljanz (tofacitinib) was associated with a higher rate of heart attacks and cancer than a TNF inhibitor in patients aged over 50 with underlying cardiovascular risk factors.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
APRIL 16, 2021
billion deal to buy Nuance Communications and its artificial intelligence platform for speech recognition that is increasingly being used for clinical applications. . Microsoft has made its aspirations in digital health clear with a whopping $19.7
PQA
FEBRUARY 29, 2024
The burden and cost of treating rare disease is high for patients, our care system and society. The economic burden of rare disease reached nearly $1 trillion in 2019, and the average drug approved under the Orphan Drug Act costs nearly $120,000 per year. In the United States, rare disease affects about one in 10 people.
The Digital Apothecary
JANUARY 23, 2021
I have given multiple international and national talks on this topic and serve as a thought leader and subject matter expert on engaging digital health in education for the upcoming future of patient care. Nonetheless, I think the following frameworks I have created with others may best represent where I think inroads could be made.
pharmaphorum
JULY 16, 2021
At the same time, trust in doctors and other providers to keep data secure dropped from 89% in 2019 to 83% last year, suggesting there is a wider, contextual shift occurring. An all-in-one, bespoke solution developed specifically with the NHS, GPs and patients in mind is the key to ticking these boxes. Be transparent.
PharmD Live
MAY 13, 2024
Understanding the balance between essential and excessive polypharmacy, recognizing its prevalence, and identifying contributing factors are crucial in mitigating its risks and enhancing patient care. “Medication Management in Long-Term Care,” Clinical Interventions in Aging , 2019). According to the U.S.
Expert insights. Personalized for you.
52 
Let's personalize your content